PFE Jan 2024 35.000 call
| Previous close | 0.9500 |
| Open | 0.9900 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 35.00 |
| Expiry date | 2024-01-19 |
| Day's range | 0.8200 - 1.0000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Business WirePfizer Broadens Portfolio of Respiratory Vaccines Recommended by CDC Advisory Committee with ABRYSVO™ for RSV
NEW YORK, September 22, 2023--Pfizer Inc. (NYSE: PFE) shared today it has broadened its portfolio of respiratory vaccines recommended by the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) following a favorable vote for ABRYSVO™ [Respiratory Syncytial Virus Vaccine], the company’s bivalent RSV prefusion F (RSVpreF) vaccine, as a maternal immunization. This is the first-ever fall in which eligible individuals can receive Pfizer vaccines
ZacksPharma Stock Roundup: EU Nod to PFE's Litfulo, FDA Priority Tag to MRK Applications
The European Commission approves Pfizer's (PFE) Litfulo for severe alopecia areata. FDA gives priority tag to Merck's (MRK) supplemental applications for Welireg and Keytruda.
Motley Fool3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Stock valuations are at historically high levels. Three Motley Fool contributors identified bargain stocks to buy in a market that's priced for perfection. Here's why they picked AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Pfizer (NYSE: PFE).
